Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study
- 26 March 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 33 (5) , 1227-1230
- https://doi.org/10.1016/s0735-1097(98)00694-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Role of endogenous opioids and catecholamines in vasovagal syncopeEuropean Heart Journal, 1996
- Pathophysiological Aspects of Neurocardiogenic Syncope: Current Concepts and New PerspectivesPacing and Clinical Electrophysiology, 1995
- Increase in plasma beta endorphins precedes vasodepressor syncope.Heart, 1994
- Neural Control Mechanisms and Vasovagal SyncopeJournal of Cardiovascular Electrophysiology, 1993
- Neurocardiogenic SyncopeNew England Journal of Medicine, 1993
- The vasovagal responseClinical Science, 1991
- Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tiltJournal of the American College of Cardiology, 1991
- HEAD-UP TILT: A USEFUL TEST FOR INVESTIGATING UNEXPLAINED SYNCOPEThe Lancet, 1986
- The Bezold-Jarisch reflex revisited: Clinical implications of inhibitory reflexes originating in the heartJournal of the American College of Cardiology, 1983
- Catecholamines in vasovagal faintingJournal of Psychosomatic Research, 1965